About the Company
The Protocols of the Elders of Zion (Russian: Протоколы сионских мудрецов), or The Protocols of the Meetings of the Learned Elders of Zion (Протоколы собраний ученых сионских мудрецов), is a fabricated text purporting to detail a Jewish plot for global domination. Largely plagiarized from several earlier sources, it was first published in Imperial Russia in 1903, translated into multiple languages, and disseminated internationally in the early part of the 20th century. It played a key part in popularizing belief in an international Jewish conspiracy. Beginning in 1933, distillations of the work were assigned by some German teachers, as if they were factual, to be read by German schoolchildren throughout Nazi Germany, although the text had been exposed as fraudulent by the British newspaper The Times in 1921 and by the German newspaper Frankfurter Zeitung in 1924. Today, it remains widely available in numerous languages, in print and on the Internet, and continues to be presented by antisemitic groups as a genuine document. It has been described as "probably the most influential work of antisemitism ever written" since it emerged from Russia shortly before World War I.
Exchange
NYSE
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $IGC News
IGC Pharma Says Cannabinoid-Based Drug Candidate Provides Fast Relief With Fewer Side Effects For Alzheimer's-Associated Agitation
IGC Pharma Inc (NYSE:IGC) released interim data from its Phase 2 clinical trial of IGC-AD1 for agitation in dementia ...
IGC Pharma Inc (IGC) Shares Decline Despite Market Challenges
The net margin for IGC Pharma Inc stands at -11.62. The total capital return value is set at -1.25. Equity return is now at value -103.36, with -90.30 for asset returns.
IGC-AD1’s Interim Phase 2 Data Show a Reduction in Alzheimer’s Agitation at Week Two
"We are excited to share that the interim results on the secondary outcome show that IGC-AD1 can provide fast relief with few ...
IGC PHARMA Announces its Participation at the Benzinga Virtual Healthcare Summit 2024
IGC Pharma, Inc. (“IGC Pharma”, “IGC”, or the “Company”) (NYSE American: IGC) today announced that Ram Mukunda, CEO, and Claudia ...
IGC Pharma Adds Advisor in Artificial Intelligence
POTOMAC, Md., April 09, 2024--(BUSINESS WIRE)--IGC Pharma, Inc. ("IGC Pharma," "IGC" or the "Company") (NYSE American: IGC) today announces the addition of Pablo ...
IGC Pharma Announces Positive Interim Results for IGC-AD1 in Reducing Alzheimer’s Agitation
POTOMAC, Md.--(BUSINESS WIRE)--IGC Pharma, Inc. (“IGC Pharma”, “IGC”, or the “Company”) (NYSE American: IGC) today announced the results of an interim analysis of its ongoing Phase 2 ...
IGC Pharma Inc
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Loading the latest forecasts...